Coronavirus vaccine: this country has achieved great success on corona vaccine, will test 30 thousand people from July 27

The first Kovid-19 vaccine tested in the US has benefited the immunity of people as scientists had expected.  Now the important trial of this vaccine has to be done.  America's top expert, Dr. Anthony Fauchi, said, "No matter how much you cut it, it is still good news."

 This news has also been published by the English newspaper New York Times.  Information related to its trial is posted on clinicaltrials.gov.  The study is still in progress and will run till October 2022.  Dr. Fauchi's colleagues at the National Institutes of Health and Moderna Inc. have developed the vaccine.

Now the most important phase of this vaccine will start from 27 July.  It will be tested on thirty thousand people and it will be known whether this vaccine can really save the human body from Kovid-19.  Researchers on Tuesday released the results of tests conducted on 45 people.  He was waiting impatiently.  Neutralizing antibodies have evolved in the body of these volunteers.  These antibodies are important to prevent infection.

 The research team has written in the New England Journal of Medicine that volunteers taking the vaccine have as many antibodies in the blood as those found in the body of patients recovering from Kovid-19.  Dr. Lisa Jackson, of the Saffron Permanent Washington Research Institute in Seattle, who led the research, says it is an essential building block to move forward in testing and find out if the vaccine can actually prevent infection.

 There is no guarantee yet when the final results will be received, but the government hopes that the trial will be completed by the end of the year.  In order to develop a vaccine, it is a record speed.  This vaccine will be given two vaccines, with a gap of one month.  This vaccine has no serious side effects.  But more than half of the people involved in the research have reported a flu-like reaction.  This is not uncommon with other vaccines.

 Headaches, feeling cold, fever, or pain in place of vaccines are common after vaccination.  These reactions were more severe among the three participants who were given higher doses.  That quantity is no longer being tested.  Some reactions are similar to symptoms of corona virus infection, but are temporary.  They last for one day and begin appearing soon after being vaccinated.

 Researcher Dr. William Schaffner, associated with Vanderbilt University Medical Center, says that this is the small cost of protection from an epidemic like Corona.  Dr. Schaffner is not involved with this research.  He described the initial results of the vaccine as a good move.  They hope that the final trial of the drug will reveal whether it is safe and effective.  These results will be available by the beginning of next year.  Schaffner says that it will be fantastic, provided everything is on its own schedule.  Moderna Inc shares rose as much as fifteen percent on the US stock market after initial results Tuesday.

 Shares of the company, based in Cambridge, Massachusetts, USA, have increased four times this year.  The research results released on Tuesday included only the youth.  Elders are also being included in the upcoming test.  The elderly most affected by the Kovid-19 epidemic have occurred.

 According to a leading news agency, the results of the research are yet to be made public and the regulator is analyzing them.  Fauchi says the last round of trials will also include the elderly.  Apart from this, people suffering from serious diseases will also be tested.  The most impact of this virus has been only on those who were suffering from some disease before.

 Not only this, people of Black and Latin origin in America have also been more affected by this infection.  Around two dozen vaccines worldwide are in the final stages of their trials.  The vaccines of Oxford University in China and Britain are also coming to the final stages of trials soon.

 The research of this vaccine, which is going to be done on thirty thousand people, will be the biggest research of the possible vaccine of Corona so far.  However, this vaccine is not the only vaccine that will be tested on a large scale.  The government is also preparing to do major research on the Oxford vaccine and the Johnson & Johnson vaccine.  In addition, the Pfizer company vaccine will also be studied extensively.

 People can register themselves as volunteers for these research.  Dr. Fauchi says that people think that one vaccine will win in this race, but I am encouraging everyone.  They say, we need many vaccines, we need the vaccine for the whole world and not for any one country.  Governments around the world are investing in vaccines, so that vaccines can be given on time if a vaccine proves effective.